|Description||Development-stage pharmaceutical company|
|Venture Round, 7/2010 ||$6.2M|
|Series B, 2/2013 |
Palisade Capital Management
Brickell Biotech, Inc., a Delaware corporation, is a development-stage pharmaceutical company focused on the acquisition, development and commercialization of innovative drug therapies for the treatment of skin diseases.